Genospace

Genospace is a software company based in the Boston/Cambridge area, founded in 2011. It specializes in cloud-based platforms that integrate clinical, genomic, and real-world data to enhance precision medicine, particularly in oncology and rare diseases. As a wholly owned subsidiary of Sarah Cannon, part of McKesson Corporation, Genospace focuses on making complex biomedical data accessible for research, clinical development, and patient care.

The company offers a comprehensive precision medicine platform with various applications. These include FullView for integrating genomic and diagnostic assay results, Population Analytics for analyzing whole-genome sequencing data, and tools for clinical trial matching. Genospace's solutions support electronic medical record transfers, accelerate drug development, and generate real-world evidence for oncology research. With over 500 community oncology clinics and research sites utilizing its platform, Genospace plays a significant role in advancing personalized treatment strategies and improving patient outcomes.